Power Law company profile

Polyplus-transfection

Biotech & Life Sciences · Illkirch, France · Founded 2001 Unicorn

Provides specialised reagents, kits and services for nucleic-acid delivery in gene and cell therapy production

Valuation

$2.5–5B

Latest valuation · 2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

3 investors on Polyplus-transfection's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Crédit Mutuel Equity

CIC Finance

Series B+ 1 investor entered at this stage

Warburg Pincus

Global footprint

Where Polyplus-transfection has talent and traffic

Workforce by country

3 countries with
team presence

🇫🇷 France92.5%

🇨🇳 China3%

🇺🇸 United States3%

3 countries shown

Patent intelligence

$17M patent portfolio · 12 active families

Estimated portfolio value

$17M

0.64% of valuation · 45.8× smaller than top peer BioNTech ($780M)

12 active patent families

Where Polyplus-transfection innovates Molecular biologyTransfectionRNA interferenceOligonucleotideRibosomal RNA Genes

Where Polyplus-transfection concentrates vs peers

Each axis is a top-10 topic across Polyplus-transfection and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Polyplus-transfection

An AI-synthesized read of the highest-engagement posts about Polyplus-transfection on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Polyplus-transfection on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles